|
02 May 2007 |
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
|
|
02 May 2007 |
Sirion Therapeutics Initiates Two Phase III Clinical Trials
|
|
02 May 2007 |
Optimer Pharmaceuticals Initiates Second Phase 3 Trial of OPT-80 for CDAD
|
|
02 May 2007 |
Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
|
|
01 May 2007 |
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
|
|
01 May 2007 |
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
|
|
01 May 2007 |
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
|
|
01 May 2007 |
Interim report about clinical trial of BF-200 ALA in actinic keratosis
|
|
28 Apr 2007 |
Diovan(R) achieved 40% reduction in stroke and cardiovascular events in landmark Jikei Heart Study
|
|
28 Apr 2007 |
Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
|
|
28 Apr 2007 |
Submission of New Drug Application for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug
|
|
28 Apr 2007 |
Schering-Plough Announces EU Approval Of Two New Formulations Of Aerius(R) (Desloratadine)
|
|
28 Apr 2007 |
Cipher Pharmaceuticals Receives Approvable Letter From Fda For CIP-ISOTRETINOIN
|
|
28 Apr 2007 |
VioQuest Pharmaceuticals Announces Phase I/IIa Trial and Enrollment Updates for Akt Inhibitor VQD-002
|
|
28 Apr 2007 |
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
|
|
28 Apr 2007 |
FDA approves once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray for treatment of seasonal and year-round allergy symptoms in adults and children as young as two years
|
|
28 Apr 2007 |
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
|
|
27 Apr 2007 |
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
|
|
27 Apr 2007 |
Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
|
|
27 Apr 2007 |
SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
|
|
27 Apr 2007 |
4SC AG: 60 Patients in Phase IIa Clinical Trial
|
|
27 Apr 2007 |
Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
|
|
26 Apr 2007 |
Exelixis Files IND Application for XL765
|
|
26 Apr 2007 |
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
|
|
26 Apr 2007 |
MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
|
